California State Teachers Retirement System (CalSTRS)’s Galectin Therapeutics GALT Stock Holding History
Other funds holding GALT
California State Teachers Retirement System (CalSTRS)'s GALT Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) opened a new position in Galectin Therapeutics (GALT) in Q2 2026: 660 shares worth $3.06K. The stake represents ﹤0.01% of the portfolio and ranks #2752 among its holdings. This is a return to the name: California State Teachers Retirement System (CalSTRS) previously reported a position in GALT as recently as Q1 2025.
California State Teachers Retirement System (CalSTRS) first reported a position in GALT in Q2 2014 and has held it in 17 quarters since. The position peaked at $454K in Q2 2014. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 660 shares of Galectin Therapeutics worth $3.06K as of Q2 2026.
- Galectin Therapeutics was a new California State Teachers Retirement System (CalSTRS) position in Q2 2026.
- Galectin Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2752 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Galectin Therapeutics in Q2 2014 and has held it in 17 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Galectin Therapeutics position peaked at $454K in Q2 2014.
- 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.